IK Investment Partners to Acquire Majority Stake in Kersia from Ardian
October 12, 2020
IK Investment Partners' IK IX Fund has entered exclusive negotiations and allocated CSR-linked financing to acquire a majority stake in Kersia from Ardian. Kersia is a global leader in biosecurity and food safety with revenues above €300m, operations in 120+ countries and more than 1,500 employees; IK intends to support the company's next stage of growth and sustainability agenda.
- Buyers
- IK Investment Partners (IK IX Fund)
- Targets
- Kersia
- Sellers
- Ardian
- Industry
- Manufacturing
- Location
- Brittany, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Kersia (Ardian-backed) Acquires Choisy Laboratories from Trudeau Family and Champlain Financial
July 18, 2019
Manufacturing
Kersia, the Ardian-backed global leader in food safety and biosecurity, has acquired Choisy Laboratories Ltd., a Quebec-based developer and manufacturer of chemical, biotechnological and biosecurity hygiene solutions, from the Trudeau family and Champlain Financial Corporation for an undisclosed amount. The deal expands Kersia's North American footprint, adds Choisy's enzymatic and biotech capabilities, and brings c.250 employees and additional R&D and manufacturing capacity into the Kersia network.
-
IK Partners Acquires Majority Stake in BIOBank
May 29, 2024
Medical Devices
IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.
-
IK Investment Partners Invests in Valoria Capital
December 22, 2020
Wealth Management
IK Investment Partners’ Small Cap II Fund has agreed to invest in Valoria Capital, a Paris-headquartered acquisition platform of independent financial advisors founded by Romain Lefèvre. Financial terms were not disclosed; IK said the investment will support Valoria’s buy-and-build strategy and portfolio diversification (financing support was provided by Idinvest Partners).
-
IK Investment Partners to Acquire Majority Stake in Eres
February 20, 2019
Wealth Management
IK Investment Partners' IK VIII Fund has entered exclusive negotiations to acquire a majority stake in French employee-savings and retirement specialist Eres alongside Eres' management team and employees. The deal will see current investor Parquest Capital exit (or reduce its stake) as IK and management look to accelerate Eres' development; financial terms were not disclosed.
-
IK Investment Partners Acquires Majority Stake in Skill & You
February 4, 2021
Education
IK Investment Partners (IK IX Fund) has entered into an exclusivity agreement to acquire the majority stake in French vocational e-learning provider Skill & You from Andera Partners. Management (led by Eric Petco and Sonia Levy-Odier) will co-invest alongside IK to support accelerated international expansion, strengthen B2G/B2B capabilities and continue product and platform investment; Skill & You reported ~€115m revenue in 2020, ~120,000 students and ~850 employees.
-
IK Partners (IK IX) Acquires Majority Stake in IG&H
July 12, 2022
IT Services
IK Partners’ IK IX Fund has agreed to acquire a majority stake in Dutch digital transformation consultancy IG&H, with the founding management team reinvesting alongside the fund. IG&H, headquartered in Utrecht with ~350 employees and offices in Lisbon, Porto and Munich, provides consultancy, data analytics, low-code development and proprietary digital solutions for clients in pensions, banking, insurance, retail and healthcare; IK will support international expansion and M&A-driven consolidation.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.